Literature DB >> 3171481

Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.

P Höglund1, H G Ljunggren, C Ohlén, L Ahrlund-Richter, G Scangos, C Bieberich, G Jay, G Klein, K Kärre.   

Abstract

The H-2Dd transgenic strain D8 on C57BL background was more resistant to subcutaneous challenge of RBL-5 lymphoma cells than B6 controls. The direct role of the H-2Dd antigen was investigated by the use of (D8 x B6)F1 crosses and (D8 B6) x B6 backcrosses. The latter showed cosegregation with regard to Dd antigen expression and lymphoma resistance, both of which were inherited in a pattern consistent with control by a single dominant gene. The rejection potential in (D8 x B6)F1 mice appeared as strong as that seen in crosses between B6 and MHC congenic mice (on B10 background) carrying H-2Dd. The lymphoma resistance could be abrogated by treatment with anti-asialo GM1 antiserum or anti-NK 1.1 mAb, indicating a role for NK cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171481      PMCID: PMC2189085          DOI: 10.1084/jem.168.4.1469

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Histocompatibility genes of mice. III. H-1 and H-4, two histocompatibility loci in the first linkage group.

Authors:  G D SNELL; L C STEVENS
Journal:  Immunology       Date:  1961-10       Impact factor: 7.397

2.  Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.

Authors:  W Schuler; I J Weiler; A Schuler; R A Phillips; N Rosenberg; T W Mak; J F Kearney; R P Perry; M J Bosma
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

3.  Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.

Authors:  V K Milisauskas; S G Kaminsky; I Nakamura
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

4.  The H-2 locus and viral leukemogenesis as studied in congenic strains of mice.

Authors:  J R Tennant; G D Snell
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

5.  Functional expression of a heterologous major histocompatibility complex class I gene in transgenic mice.

Authors:  C Bieberich; T Yoshioka; K Tanaka; G Jay; G Scangos
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

6.  T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of scid mice.

Authors:  M M Tutt; W Schuler; W A Kuziel; P W Tucker; M Bennett; M J Bosma; V Kumar
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

7.  Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.

Authors:  R M Rembecki; M Bennett; V Kumar; T A Potter
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

8.  Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.

Authors:  W E Seaman; M Sleisenger; E Eriksson; G C Koo
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

9.  A transgenic class I antigen is recognized as self and functions as a restriction element.

Authors:  T Yoshioka; C Bieberich; G Scangos; G Jay
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

10.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

View more
  24 in total

Review 1.  Current perspectives of natural killer cell education by MHC class I molecules.

Authors:  Petter Höglund; Petter Brodin
Journal:  Nat Rev Immunol       Date:  2010-09-06       Impact factor: 53.106

Review 2.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Transgenic mouse model for central nervous system demyelination.

Authors:  T Yoshioka; L Feigenbaum; G Jay
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.

Authors:  Philomena Kamya; Salix Boulet; Christos M Tsoukas; Jean-Pierre Routy; Réjean Thomas; Pierre Côté; Mohamed-Rachid Boulassel; Jean-Guy Baril; Colin Kovacs; Stephen A Migueles; Mark Connors; Todd J Suscovich; Christian Brander; Cecile L Tremblay; Nicole Bernard
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

Review 5.  Use of allogeneic NK cells for cancer immunotherapy.

Authors:  Melissa A Geller; Jeffrey S Miller
Journal:  Immunotherapy       Date:  2011-12       Impact factor: 4.196

6.  Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.

Authors:  Petter Brodin; Tadepally Lakshmikanth; Ramit Mehr; Maria H Johansson; Adil Doganay Duru; Adnane Achour; Mali Salmon-Divon; Klas Kärre; Petter Höglund; Sofia Johansson
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

7.  Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype.

Authors:  D Polsky; F Lilly
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.

Authors:  P Höglund; C Ohlén; E Carbone; L Franksson; H G Ljunggren; A Latour; B Koller; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  Hemopoietic histocompatibility (Hh-1) phenotype and the regulation of its expression.

Authors:  S G Kaminsky; M A Yoshida; V K Milisauskas; I Nakamura
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Natural killer cell inhibitory receptor expression in humans and mice: a closer look.

Authors:  Michal Sternberg-Simon; Petter Brodin; Yishai Pickman; Björn Onfelt; Klas Kärre; Karl-Johan Malmberg; Petter Höglund; Ramit Mehr
Journal:  Front Immunol       Date:  2013-03-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.